Virax Biolabs cash flow statement data for the quarter ended Mar 2026. This cash flow statement covers 10 quarters of results from Mar 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow StatementCash Flow | Mar2021 | Mar2022 | Sep2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Additional items | ||||||||||
| Ending Cash Balance | 0.02M | 0.02M | 4.57M | 9.35M | 5.11M | 3.59M | 7.29M | 4.23M | 3.35M | 6.44M |
Pull Virax Biolabs's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=VRAX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "VRAX", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=VRAX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();